JPS6466184A - Pyrroloisoquinolines - Google Patents

Pyrroloisoquinolines

Info

Publication number
JPS6466184A
JPS6466184A JP63197280A JP19728088A JPS6466184A JP S6466184 A JPS6466184 A JP S6466184A JP 63197280 A JP63197280 A JP 63197280A JP 19728088 A JP19728088 A JP 19728088A JP S6466184 A JPS6466184 A JP S6466184A
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
formula
aryl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63197280A
Other languages
English (en)
Inventor
Jiyon Atsushiyuton Maikeru
Ian Doron Donarudo
Fuenton Garii
Jiyon Risugoo Debitsudo
Guregorii Niyuuto Kurisutofuaa
Rideru Debitsudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
May and Baker Ltd
Original Assignee
May and Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May and Baker Ltd filed Critical May and Baker Ltd
Publication of JPS6466184A publication Critical patent/JPS6466184A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
JP63197280A 1987-08-11 1988-08-09 Pyrroloisoquinolines Pending JPS6466184A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878718980A GB8718980D0 (en) 1987-08-11 1987-08-11 Compositions of matter

Publications (1)

Publication Number Publication Date
JPS6466184A true JPS6466184A (en) 1989-03-13

Family

ID=10622128

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63197280A Pending JPS6466184A (en) 1987-08-11 1988-08-09 Pyrroloisoquinolines

Country Status (16)

Country Link
US (1) US4933350A (ja)
EP (1) EP0303446B1 (ja)
JP (1) JPS6466184A (ja)
KR (1) KR890003758A (ja)
AT (1) ATE106079T1 (ja)
AU (1) AU2053088A (ja)
DE (1) DE3889699D1 (ja)
DK (1) DK444488A (ja)
FI (1) FI883700A (ja)
GB (1) GB8718980D0 (ja)
HU (1) HU201070B (ja)
IL (1) IL87384A0 (ja)
NZ (1) NZ225763A (ja)
OA (1) OA08898A (ja)
PT (1) PT88226B (ja)
ZA (1) ZA885852B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1347973A1 (en) 2000-12-13 2003-10-01 Bayer Aktiengesellschaft Pyrrolo (2.1-a) dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors
TW200944523A (en) * 2008-02-08 2009-11-01 Organon Nv (Dihydro)pyrrolo[2,1-a]isoquinolines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3019232A (en) * 1958-12-18 1962-01-30 Ajinomoto Kk Process for producing synthetic tryptophane
DE1261125B (de) * 1958-12-18 1968-02-15 Ajinomoto Kk Verfahren zur Herstellung von 5-[Indolyl-(3)-methyl]-hydantoin
BE690792A (ja) * 1966-12-07 1967-05-16
ZA844402B (en) * 1983-06-23 1986-01-29 Mcneil Pharmaceutical Hexahydropyrrolo(2,1-a)isoquinoline derivatives
DE3401018A1 (de) * 1984-01-13 1985-07-18 Boehringer Ingelheim KG, 6507 Ingelheim Verfahren zur herstellung von 5,6-dihydro-pyrrolo(2,1-a)isochinolinen
DE3633840A1 (de) * 1986-10-04 1988-04-14 Hoechst Ag Phenylpyrazolcarbonsaeurederivate, ihre herstellung und verwendung als pflanzenwachstumsregulatoren und safener

Also Published As

Publication number Publication date
DK444488D0 (da) 1988-08-09
HU201070B (en) 1990-09-28
ATE106079T1 (de) 1994-06-15
HUT48243A (en) 1989-05-29
ZA885852B (en) 1989-04-26
PT88226A (pt) 1989-06-30
EP0303446A1 (en) 1989-02-15
KR890003758A (ko) 1989-04-17
GB8718980D0 (en) 1987-09-16
FI883700A (fi) 1989-02-12
EP0303446B1 (en) 1994-05-25
OA08898A (en) 1989-10-31
PT88226B (pt) 1995-03-01
FI883700A0 (fi) 1988-08-09
IL87384A0 (en) 1989-01-31
DK444488A (da) 1989-02-12
US4933350A (en) 1990-06-12
AU2053088A (en) 1989-02-16
DE3889699D1 (de) 1994-06-30
NZ225763A (en) 1991-01-29

Similar Documents

Publication Publication Date Title
HU906029D0 (en) Process for the preparation of pleuromuthylyne derivatives
HUT52059A (en) Process for producing pharmaceutical compositions and new quinoline derivatives as a group of active components
IE822026L (en) Imidazotetrazinones
EP0326386A3 (en) Isoquinolinones
IL114785A0 (en) Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them
GR3006490T3 (ja)
HU9200656D0 (en) Method for producing morpholinyl derivatives of doxorubicine and pharmaceutical preparatives containing said compounds
CA2223634A1 (en) Preparation of n-substituted 3-hydroxypyrazoles
CA2275253A1 (en) Method for producing n-substituted 3-hydroxypyrazoles
OA08898A (en) Pyrroloisoquinolines.
CA2230824A1 (en) Process for the preparation of galanthamine and its derivatives
GB8728314D0 (en) New compositions of matter
AU2037188A (en) 7-(2-methyl-4-aminopyrrolidinyl) 4-oxo-naphthyridine and quinoline derivatives
GR3021045T3 (en) 1-Alkyl-2-acyl-1,2-disulfonylhydrazines with antineoplastic activity
IE781734L (en) Preparation of derivatives of benzofuran, chromene and¹isochromene
IE810004L (en) Rifamycin derivatives
EP0250814A3 (en) Prophylactic and curing composition containing a 8-chlorobenzothiazepine compound and its use
AR242030A1 (es) Procedimiento para la preparacion de la forma 2 cristalina del hidrocloruro de ranitidina.